Medical Specialties Distributors, a portfolio company of Water Street Healthcare Partners, has acquired Medical Technology Resources. Water Street first invested in Medical Specialties Distributors in 2010.
Medical Technology Resources (MTR) specializes in providing infusion pumps and related products, as well as biomedical and billing services, to alternate-site health care providers. The company is based in Columbus, OH (www.mtrhealth.com).
Medical Specialties Distributors (MSD) is a provider of infusion products, supplies, biomedical and distribution services, and technology services to the home infusion and oncology markets. MSD serves a base of 2,500 customers, including specialty pharmacies, home infusion companies and oncology clinics. The company is based in Stoughton, MA (www.msdonline.com).
“We identified MTR as an ideal acquisition for MSD several years ago. MTR builds on MSD’s core capabilities in product distribution and biomedical services and increases its presence in the Midwest geography. Longer-term, it expands MSD’s unique position as the leading national distributor dedicated to serving the growing numbers of home infusion providers,” said Rob Womsley, a partner with Water Street and chairman of MSD.
Water Street Healthcare Partners targets investments ranging from $50 to $500 million in four health care sectors: distribution, medical products, health care services, and pharmaceutical products and services. The firm has particular expertise in corporate divestitures from healthcare companies. Water Street has more than $1 billion of capital under management and is based in Chicago (www.waterstreet.com).
“MTR’s unique product offerings and strong presence in the Midwest enhances our leadership position in the growing home infusion and oncology markets,” said James Beck, president and CEO, MSD. “Over the past three years, we have grown our national footprint through partnerships with multi-site health care providers and strategic relationships with leading manufacturers. This acquisition is one more step toward our goal of creating a stronger growth platform for MSD.”
© 2013 PEPD • Private Equity’s Leading News Magazine • 6-11-13